BlackRock Inc. - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2022$565,000
-25.4%
657,182
-2.8%
0.00%
Q2 2022$757,000
-9.9%
676,032
-9.8%
0.00%
Q1 2022$840,000
+11.6%
749,601
+59.2%
0.00%
Q4 2021$753,000
+2051.4%
470,872
+3192.8%
0.00%
Q3 2021$35,000
-14.6%
14,300
+10.3%
0.00%
Q2 2021$41,000
+4000.0%
12,959
+7753.9%
0.00%
Q1 2021$1,0001650.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,854,278$6,638,0003.61%
Asymmetry Capital Management, L.P. 739,812$2,649,0001.21%
Affinity Asset Advisors, LLC 625,000$2,238,0001.19%
Tri Locum Partners LP 728,710$2,609,0000.95%
Boxer Capital, LLC 6,226,673$22,291,0000.72%
DAFNA Capital Management LLC 668,148$2,392,0000.71%
Vivo Capital, LLC 4,220,938$15,111,0000.67%
Delphi Management Partners VIII, L.L.C. 256,734$919,0000.60%
SILVERARC CAPITAL MANAGEMENT, LLC 280,000$1,002,0000.58%
Rubric Capital Management LP 1,853,417$6,635,0000.49%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders